A 3-Week, Open Label Study to Evaluate the Efficacy and Safety of Extended Release Quetiapine Fumarate in the Treatment of Agitation in Patients with Schizophrenia

A 3-Week, Open Label Study to Evaluate the Efficacy and Safety of Extended Release Quetiapine Fumarate in the Treatment of Agitation in Patients with Schizophrenia

Objective: To evaluate the efficacy of extended-release quetiapine fumarate (XR) monotherapy once daily, in the treatment of patients with acute episodes of schizophrenia and agitation. Method: Our study was a 3-week open-label study conducted in adult in- or outpatients with schizophrenia. Quetia...

Full description

Bibliographic Details
Main Authors: Koh, Ong Hui, Sulaiman, Ahmad Hatim, Gill, Jesjeet Singh, Pillai, Subash Kumar, Jambunathan, Stephan Thevananthan, Rashid, Rusdi Abdul
Format: Article
Language:English
Published: Taylor & Francis 2013
Subjects:
R Medicine (General)
Online Access:http://eprints.um.edu.my/9622/1/00000797_93562.pdf

Similar Items

Similar Items